Citadel Advisors’s HUTCHMED HCM Stock Holding History
Bought
Maintained
Sold
Other funds holding HCM
AG
MGP
CGH
Citadel Advisors's HCM Position: Q1 2026 in Review
Citadel Advisors increased its HUTCHMED (HCM) stake by 18% in Q1 2026, buying an estimated $69.4K and bringing the position to 30,514 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #9520.
Citadel Advisors first reported a position in HCM in Q1 2018 and has held it in 26 quarters since. The position peaked at $3.21M in Q4 2022. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.
- Citadel Advisors held 30,514 shares of HUTCHMED worth $456K as of Q1 2026.
- Citadel Advisors bought 4,747 HUTCHMED shares in Q1 2026, an estimated $69.4K.
- HUTCHMED made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9520 holding.
- Citadel Advisors first reported a position in HUTCHMED in Q1 2018 and has held it in 26 quarters since.
- Citadel Advisors's HUTCHMED position peaked at $3.21M in Q4 2022.
- 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.